
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Insight on the Possible Association between Inflammatory Bowel Disease and Biologic Therapy with IL-17 Inhibitors in Psoriasis Patients
Olguța Anca Orzan, Cristian Tieranu, Andrei Ovidiu Olteanu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2171-2171
Open Access | Times Cited: 7
Olguța Anca Orzan, Cristian Tieranu, Andrei Ovidiu Olteanu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2171-2171
Open Access | Times Cited: 7
Showing 7 citing articles:
Signaling pathways and targeted therapies for psoriasis
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 108
Jia Guo, H. Zhang, Wenrui Lin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 108
IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function
Huixia Zhao, Lili Shang, Yuting Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Huixia Zhao, Lili Shang, Yuting Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
Ronghui Li, Haibo Lei, Chunjiang Wang, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Ronghui Li, Haibo Lei, Chunjiang Wang, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
New-Onset, Treatment-Resistant Inflammatory Bowel Disease after Administration of Secukinumab for Plaque Psoriasis: A Case Report and Review of the Existing Literature
Michail Krikelis, Evgenia Papathanasiou, G Leonidakis, et al.
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. 1, pp. 150-150
Open Access | Times Cited: 3
Michail Krikelis, Evgenia Papathanasiou, G Leonidakis, et al.
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. 1, pp. 150-150
Open Access | Times Cited: 3
Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection
Shadi Tabbarah, Hakam Sulaiman, Frank Owusu, et al.
Cureus (2024)
Open Access | Times Cited: 2
Shadi Tabbarah, Hakam Sulaiman, Frank Owusu, et al.
Cureus (2024)
Open Access | Times Cited: 2
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience
Luca Mastorino, Paolo Dapavo, Caterina Cariti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 718-718
Open Access | Times Cited: 1
Luca Mastorino, Paolo Dapavo, Caterina Cariti, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 718-718
Open Access | Times Cited: 1
Rare Case Report of Primary Active Pulmonary Tuberculosis During Ixekizumab Treatment for Plaque Psoriasis
Yuan Li, Jiejie Lu, Jingqiu Fu
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 1723-1728
Open Access | Times Cited: 1
Yuan Li, Jiejie Lu, Jingqiu Fu
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 1723-1728
Open Access | Times Cited: 1